The United States Pharmacopeia (USP), the U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) and The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), have announced a research collaboration to assess analytical methods and develop standards for adeno-associated virus (AAV), an...

NEWARK, Del. & ALEXANDRIA, Va., April 18, 2019 - The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in partnership with the Healthcare Innovation Special Interest Group (HISIG) of the National Society of Black Engineers (NSBE) are pleased to announce the selection of seven students for the inaugural NIIMBL eXperience...

A little over two years ago, NIIMBL, a manufacturing USA institute, began with a vision to accelerate biopharmaceutical manufacturing innovation in the United States. Stakeholders from all areas of the biopharmaceutical community have come together to put that vision into motion. The community has focused on the technologies and training programs...

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and BioPhorum Operations Group (BPOG) and have entered into a collaboration agreement to develop a US-specific roadmap for the biopharmaceutical manufacturing industry. The roadmap will complement the existing BPOG global roadmap.

The US-specific Roadmap will...

Today in Newark, Delaware, Department of Commerce Secretary Penny Pritzker announced the newest institute in the Manufacturing USA network, and the first to be awarded by the National Institute of Standards and Technology (NIST) from an ”open topic” competition. The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is a...